Datadog To Rally Around 25%? Here Are 10 Top Analyst Forecasts For Wednesday
Portfolio Pulse from Avi Kapoor
Wall Street analysts have updated their price targets and ratings for several US-listed companies, impacting their stock prices. Notably, Datadog's price target was raised from $130 to $140 by Baird with an upgrade to Outperform, despite a recent 11.5% drop in its shares. ZoomInfo Technologies saw a downgrade from Piper Sandler, with a price target cut from $24 to $15, following a 3.6% decline in its shares. Other companies such as MoneyLion, Orthofix Medical, McKesson, Occidental Petroleum, Confluent, Nasdaq, Crexendo, and Jack in the Box also experienced changes in their analyst ratings and price targets.
May 08, 2024 | 12:43 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Rosenblatt downgraded Nasdaq from Buy to Neutral and cut its price target from $76 to $64, after a 1.1% decrease in its shares.
The downgrade and reduced price target by Rosenblatt, following a slight share price decline, suggest concerns about Nasdaq's near-term outlook, likely leading to a negative short-term impact on its stock price.
CONFIDENCE 75
IMPORTANCE 75
RELEVANCE 80
NEGATIVE IMPACT
Piper Sandler downgraded ZoomInfo Technologies from Overweight to Neutral and cut its price target from $24 to $15 after a 3.6% decline in shares.
The downgrade and reduced price target by Piper Sandler, following a share price decline, indicate concerns about ZoomInfo's near-term prospects, likely leading to a negative short-term impact on its stock price.
CONFIDENCE 80
IMPORTANCE 85
RELEVANCE 90
NEUTRAL IMPACT
Piper Sandler maintained a Neutral rating on Jack in the Box and cut its price target from $81 to $67, after a marginal 0.02% increase in its shares.
The maintained Neutral rating and reduced price target by Piper Sandler, despite a slight increase in share price, indicate a cautious stance towards Jack in the Box, likely leading to a neutral short-term impact on its stock price.
CONFIDENCE 70
IMPORTANCE 65
RELEVANCE 70
NEUTRAL IMPACT
Mizuho slightly increased Occidental Petroleum's price target from $70 to $71, maintaining a Neutral rating, after a 0.1% gain in its shares.
The slight increase in price target by Mizuho, despite maintaining a Neutral rating, suggests a cautious optimism towards Occidental Petroleum, likely leading to a neutral short-term impact on its stock price.
CONFIDENCE 70
IMPORTANCE 65
RELEVANCE 70
POSITIVE IMPACT
Canaccord Genuity upgraded Confluent to Buy from Hold and raised its price target from $28 to $35, despite a 2.8% drop in its shares.
The upgrade and increased price target by Canaccord Genuity, despite a recent share price decline, indicate a strong belief in Confluent's recovery and growth potential, likely leading to a positive short-term impact on its stock price.
CONFIDENCE 75
IMPORTANCE 75
RELEVANCE 80
POSITIVE IMPACT
B. Riley Securities upgraded Crexendo to Buy from Neutral and lowered its price target from $6.75 to $5.75, after a 2.1% drop in its shares.
The upgrade by B. Riley Securities, despite a lower price target and recent share price decline, suggests a belief in Crexendo's fundamental value, potentially leading to a positive short-term impact on its stock price.
CONFIDENCE 75
IMPORTANCE 75
RELEVANCE 80
POSITIVE IMPACT
Baird upgraded Datadog to Outperform and raised its price target from $130 to $140, despite a recent 11.5% drop in share price.
The upgrade and increased price target by Baird, despite the recent drop in share price, suggest a strong confidence in Datadog's future performance, potentially leading to a positive short-term impact on its stock price.
CONFIDENCE 80
IMPORTANCE 85
RELEVANCE 90
POSITIVE IMPACT
Baird raised McKesson's price target from $603 to $671 and maintained an Outperform rating, after a 2.3% increase in its shares.
The raised price target and maintained Outperform rating by Baird, following a share price increase, reflect confidence in McKesson's performance, likely leading to a positive short-term impact on its stock price.
CONFIDENCE 75
IMPORTANCE 75
RELEVANCE 80
POSITIVE IMPACT
Needham maintained a Buy rating on MoneyLion and increased its price target from $90 to $100, following a slight 0.2% increase in its shares.
The increased price target and maintained Buy rating by Needham, after a slight share price increase, suggest optimism about MoneyLion's growth prospects, potentially leading to a positive short-term impact on its stock price.
CONFIDENCE 75
IMPORTANCE 75
RELEVANCE 80
POSITIVE IMPACT
Roth MKM upgraded Orthofix Medical from Neutral to Buy and raised its price target from $15 to $20, after a 3.2% rise in its shares.
The upgrade and increased price target by Roth MKM, following a share price rise, indicate a positive outlook for Orthofix Medical, suggesting a potential short-term positive impact on its stock price.
CONFIDENCE 75
IMPORTANCE 75
RELEVANCE 80